BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23700053)

  • 1. Cytogenetic aspects of childhood leukemias.
    Lampert F; Harbott J; Borkhardt A
    Klin Padiatr; 2013 May; 225 Suppl 1():S30-3. PubMed ID: 23700053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice.
    Salto-Tellez M; Shelat SG; Benoit B; Rennert H; Carroll M; Leonard DG; Nowell P; Bagg A
    J Mol Diagn; 2003 Nov; 5(4):231-6. PubMed ID: 14573782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome analysis of and genetic testing for myeloid leukemia].
    Yokota H; Yatomi Y
    Nihon Rinsho; 2009 Oct; 67(10):1911-5. PubMed ID: 19860189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
    Poppe B; De Paepe A; Speleman F
    Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach.
    Nasedkina TV; Zharinov VS; Isaeva EA; Mityaeva ON; Yurasov RN; Surzhikov SA; Turigin AY; Rubina AY; Karachunskii AI; Gartenhaus RB; Mirzabekov AD
    Clin Cancer Res; 2003 Nov; 9(15):5620-9. PubMed ID: 14654544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in molecular cytogenetics of leukemia].
    Abe T
    Rinsho Ketsueki; 1993 Mar; 34(3):251-9. PubMed ID: 8479075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
    Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
    Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
    Gamerdinger U; Teigler-Schlegel A; Pils S; Bruch J; Viehmann S; Keller M; Jauch A; Harbott J
    Genes Chromosomes Cancer; 2003 Mar; 36(3):261-72. PubMed ID: 12557226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
    Michalová K
    Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
    Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
    Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in acute leukemia patients.
    van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
    Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.
    Andersson A; Ritz C; Lindgren D; Edén P; Lassen C; Heldrup J; Olofsson T; Råde J; Fontes M; Porwit-Macdonald A; Behrendtz M; Höglund M; Johansson B; Fioretos T
    Leukemia; 2007 Jun; 21(6):1198-203. PubMed ID: 17410184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics and oncogenes in leukemia.
    Baer MR; Bloomfield CD
    Curr Opin Oncol; 1992 Feb; 4(1):24-32. PubMed ID: 1591291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current status of leukemia genetic testing and the trial of its standardization].
    Satoh Y; Yokota H; Kageyama Y; Ono Y; Yatomi Y
    Rinsho Byori; 2008 May; 56(5):395-401. PubMed ID: 18546889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.